Jubilant is at the forefront of
pharmaceutical, Life Sciences & healthcare innovation as it pursues
its mission to enable affordable healthcare to patients worldwide.
Jubilant Life Sciences using advanced science & technology provides
product and services that enable, the global pharmaceutical and
healthcare companies, our collaborators and customers, to gain
competitive advantage through our environment friendly, innovative and
cost effective solutions.
Jubilant’s innovation is driven by the commitment and passion of
its people to science and technology. Jubilant’s commitment to
innovation is demonstrated by enabling the innovative abilities of its
scientists and managers at all levels something that all collaborators
admire in our partnership endeavors.
Jubilant’s emphasis towards innovation is demonstrated by its
significant investments in this area to create new technologies that
will create first in class products and services across the entire
pharmaceutical value chain from target identification to custom
manufacturing through to affordable Health care delivery.
The Jubilant business model enables innovation across 3 spectrums of
the industry to include:
- Drug Discovery and Development : Therapeutically aligned: Target
Identification, Discovery and preclinical development, Clinical
Development and Biomarker research including Tissue banking etc.
- Small Molecule Development and manufacturing across building
blocks, intermediates, API’s and Formulation products,
including Sterile injectibles, Allergy and Radio pharmaceutical
products.
- Health Care Delivery in India: enabling low cost affordable
Health care delivery thru networked hospitals in semi urban areas of
West Bengal.
Over 2000 scientists and technologies across these 3 important
components of the pharmaceutical and healthcare value chain enable
affordable innovation resulting in high quality products services for
industry and patients worldwide. Jubilant’s strategy to leverage
the intellectual talent pool within the organization and from its
collaborative arrangements with thought leaders from the academia,
industry and state run institutions alike continue to drive its vision
of enabling affordable care for various unmet needs in therapeutic areas
of Oncology, Metabolic Diseases, CNS and Infectious diseases across the
world.
Jubilant’s Value proposition to big pharma and biotech is
- Providing high quality and low cost drug discovery and
development services for expanding pipeline of innovative products
- Offering products from pre- clinical to clinical, intermediate to
finished products at speedier, high quality lower cost
- Offering contract manufacturing services at substantially lower
cost than their internal cost with high quality and on time
deliveries
- Providing complete life cycle management from pre to post patent
expiry of innovative products
Development
Solutions (DDDS)